Fetal and Neonatal Heart Monitor Market: Concerted Efforts to Reduce Preterm Births Driving Adoption in Hospitals and Neonatal Clinics
Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share. Heart-related congenitala disorders in the course of pregnancy or the requirement for medical interventions owing to complications such as umbilical cord compression or premature delivery. Women experiencing high risk pregnancy factors such as diabetes, high blood pressure, gestational blood pressure and preeclampsia, who need continuous monitoring to ensure baby’s wellbeing may find fetal and neonatal heart monitor beneficial. In addition, rise in preterm birth has further signified the importance of fetal and neonatal heart rate monitor. Get Free Sample Report Here: ht...